Global Terlipressin for Injection Supply, Demand and Key Producers, 2023-2029

Global Terlipressin for Injection Supply, Demand and Key Producers, 2023-2029

The global Terlipressin for Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.

This report studies the global Terlipressin for Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Terlipressin for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Terlipressin for Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Terlipressin for Injection total production and demand, 2018-2029, (K Units)

Global Terlipressin for Injection total production value, 2018-2029, (USD Million)

Global Terlipressin for Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Terlipressin for Injection consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Terlipressin for Injection domestic production, consumption, key domestic manufacturers and share

Global Terlipressin for Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Terlipressin for Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Terlipressin for Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Terlipressin for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure and Criticine Care, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Terlipressin for Injection market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Terlipressin for Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Terlipressin for Injection Market, Segmentation by Type
Lumps
Powder

Global Terlipressin for Injection Market, Segmentation by Application
Internal Medicine Application
surgical application
Intensive Care Unit (ICU) Applications

Companies Profiled:
Ferring Pharmaceuticals
Ranbaxy UK Ltd
TAJ LIFE SCIENCES
Mallinckrodt plc
EVER Pharma
Alliance Pharmaceuticals
Serum Institute of India Pvt. Ltd
Biovenice Criticure
Criticine Care
Integrated Laboratories Pvt Ltd
Hybio Pharmaceutical Co., Ltd
Fujian Mindong Rejuenation Pharmaceutical Co., Ltd
Hangzhou Ausia Biological Technology Company, Ltd
Nanjing Kangzhou Pharmaceutical Technology Co., Ltd
Hainan General Sanyang Pharmaceutical Co., Ltd

Key Questions Answered

1. How big is the global Terlipressin for Injection market?

2. What is the demand of the global Terlipressin for Injection market?

3. What is the year over year growth of the global Terlipressin for Injection market?

4. What is the production and production value of the global Terlipressin for Injection market?

5. Who are the key producers in the global Terlipressin for Injection market?

6. What are the growth factors driving the market demand?